(Q44813445)

6 December 2017

title

Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma (English)

1 reference

6 December 2017

1 reference

4

Yoshihiko Maehara

1 reference

6 December 2017

Riichiroh Maruyama

1

1 reference

6 December 2017

Kenji Sugio

series ordinal

2

1 reference

6 December 2017

Ichiro Yoshino

series ordinal

3

1 reference

6 December 2017

Adi F Gazdar

series ordinal

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

100

1 reference

6 December 2017

issue

7

1 reference

6 December 2017

page(s)

1472-1477

1 reference

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

The H-cadherin (CDH13) gene is inactivated in human lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

The FHIT gene 3p14.2 is abnormal in lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Mutations of the APC (adenomatous polyposis coli) gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20144

7 January 2021

Identifiers

DOI

10.1002/CNCR.20144

1 reference

6 December 2017

1 reference